Kalogon, a biotechnology company specializing in the development of innovative therapies for the treatment of cancer, raised $1.2M in funding to accelerate the development of its proprietary cancer treatment technologies and expand its research capabilities. (Published by Fins...
Kalogon raised $1.2M in funding to accelerate the development of its proprietary cancer treatment technologies and expand its research capabilities
Jun 24, 2024
—